Friday, October 12, 2007

Lupin Further Assigned Patent Rights Over Antihypertensive Drug

Earlier this year, Pune-based Lupin Ltd. assigned its patent right (process patents) over antihypertensive drug perindopril to French company Laboratories Servier for 20 million euros, now further to the development Lupin has assigned additional patent rights for additional 20 million euros. Perindopril patent assignment is one of the significant commercial transactions made by an Indian company from its intellectual property portfolio.

No comments:

Post a Comment